However, those who started ART with <200 CD4 cells/μl seem to have increased rates, compared to the “High CD4” group in several cases: unadjusted comparisons, allowing for competing risks, showed significantly increased rates of SNAEs or non-AIDS deaths (p = 0.001), fatal events (p = 0.001) and non-AIDS/CVD/NADM related events (mainly deaths from other causes; p = 0.009). Here, CD4 is linked to AIDS.